| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.746 | 0.002 | 0.792 | Aldehyde dehydrogenase inhibitor | 0.792 0.002 CID_3035711 | CID_3035711 | |
| 0.557 | 0.025 | 0.582 | Aldehyde oxidase inhibitor | 0.582 0.021 CID_3035711 | CID_3035711 | |
| 0.396 | 0.015 | 0.396 | 5 Hydroxytryptamine uptake stimulant | 0.321 0.035 CID_3035711 | ||
| 0.372 | 0.012 | 0.372 | Tyrosine 3 hydroxylase inhibitor | 0.344 0.017 CID_3035711 | ||
| 0.388 | 0.048 | 0.419 | 5 Hydroxytryptamine release stimulant | 0.419 0.042 CID_3035711 | CID_3035711 | |
| 0.384 | 0.069 | 0.384 | GABA C receptor rho-3 antagonist | 0.308 0.11 CID_3035711 | ||
| 0.384 | 0.084 | 0.384 | Histamine release inhibitor | 0.253 0.153 CID_3035711 | ||
| 0.332 | 0.041 | 0.332 | Superoxide dismutase inhibitor | 0.217 0.1 CID_3035711 | ||
| 0.334 | 0.061 | 0.334 | Calcium channel activator | 0.332 0.063 CID_3035711 | ||
| 0.276 | 0.006 | 0.276 | Porphobilinogen synthase inhibitor | 0.247 0.008 CID_3035711 | ||
| 0.272 | 0.008 | 0.272 | Telomerase inhibitor | 0.211 0.013 CID_3035711 | ||
| 0.267 | 0.02 | 0.267 | Alpha-N-acetylglucosaminidase inhibitor | 0.208 0.032 CID_3035711 | ||
| 0.255 | 0.014 | 0.255 | 5 Hydroxytryptamine 3E antagonist | 0.237 0.023 CID_3035711 | ||
| 0.267 | 0.043 | 0.267 | Anesthetic general | |||
| 0.204 | 0.004 | 0.204 | Elastase inhibitor | 0.099 0.01 CID_3035711 | ||
| 0.247 | 0.048 | 0.247 | Peroxidase inhibitor | 0.182 0.065 CID_3035711 | ||
| 0.336 | 0.146 | 0.336 | MAP kinase 1 inhibitor | |||
| 0.198 | 0.009 | 0.198 | Prolactin inhibitor | 0.136 0.029 CID_3035711 | ||
| 0.314 | 0.129 | 0.314 | Beta lactamase inhibitor | |||
| 0.333 | 0.16 | 0.333 | Caspase 9 stimulant | |||
| 0.337 | 0.165 | 0.337 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.282 0.238 CID_3035711 | ||
| 0.254 | 0.093 | 0.254 | Insulysin inhibitor | 0.203 0.152 CID_3035711 | ||
| 0.162 | 0.01 | 0.162 | Phenylalanine 4-hydroxylase inhibitor | 0.117 0.019 CID_3035711 | ||
| 0.177 | 0.028 | 0.177 | Adenylate cyclase stimulant | 0.146 0.069 CID_3035711 | ||
| 0.184 | 0.037 | 0.184 | Anesthetic local | |||
| 0.187 | 0.046 | 0.187 | Arachidonic acid antagonist | 0.136 0.105 CID_3035711 | ||
| 0.167 | 0.028 | 0.167 | GABA C receptor agonist | 0.128 0.044 CID_3035711 | ||
| 0.3 | 0.165 | 0.3 | 5 Hydroxytryptamine release inhibitor | |||
| 0.145 | 0.019 | 0.145 | NADH dehydrogenase inhibitor | 0.131 0.023 CID_3035711 | ||
| 0.197 | 0.074 | 0.197 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.135 CID_3035711 | ||
| 0.161 | 0.039 | 0.161 | Cyclooxygenase 3 inhibitor | |||
| 0.155 | 0.035 | 0.155 | Ferrochelatase inhibitor | 0.111 0.061 CID_3035711 | ||
| 0.206 | 0.091 | 0.206 | RNA-directed DNA polymerase inhibitor | |||
| 0.15 | 0.038 | 0.15 | Aminopeptidase B inhibitor | 0.099 0.066 CID_3035711 | ||
| 0.123 | 0.012 | 0.123 | Acyl-CoA dehydrogenase inhibitor | 0.078 0.023 CID_3035711 | ||
| 0.135 | 0.025 | 0.135 | Triose-phosphate isomerase inhibitor | 0.126 0.029 CID_3035711 | ||
| 0.131 | 0.023 | 0.131 | Histamine N-methyltransferase inhibitor | |||
| 0.149 | 0.044 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.138 0.082 CID_3035711 | ||
| 0.209 | 0.104 | 0.209 | Neuropeptide Y2 antagonist | |||
| 0.166 | 0.068 | 0.166 | Anticoagulant | |||
| 0.132 | 0.035 | 0.132 | Adenylate kinase inhibitor | 0.114 0.049 CID_3035711 | ||
| 0.157 | 0.065 | 0.157 | GABA C receptor rho-2 antagonist | 0.129 0.107 CID_3035711 | ||
| 0.206 | 0.114 | 0.206 | DNA synthesis inhibitor | |||
| 0.132 | 0.041 | 0.132 | Butyrylcholinesterase inhibitor | |||
| 0.215 | 0.126 | 0.215 | Gastrin inhibitor | 0.211 0.132 CID_3035711 | ||
| 0.167 | 0.084 | 0.167 | Succinate dehydrogenase inhibitor | 0.152 0.108 CID_3035711 | ||
| 0.097 | 0.017 | 0.097 | Protease 3C (Human rhinovirus) inhibitor | 0.092 0.019 CID_3035711 | ||
| 0.124 | 0.044 | 0.124 | Protease inhibitor | |||
| 0.23 | 0.154 | 0.23 | Vasodilator, coronary | |||
| 0.197 | 0.122 | 0.238 | Immunostimulant | 0.238 0.101 CID_3035711 | CID_3035711 | |
| 0.123 | 0.049 | 0.123 | Nav1.4 sodium channel blocker | |||
| 0.099 | 0.026 | 0.099 | Estrogen-related receptor beta agonist | 0.087 0.048 CID_3035711 | ||
| 0.106 | 0.034 | 0.106 | Glutamate release inhibitor | |||
| 0.087 | 0.018 | 0.087 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.07 0.026 CID_3035711 | ||
| 0.129 | 0.06 | 0.129 | Alkylator | 0.128 0.061 CID_3035711 | ||
| 0.198 | 0.133 | 0.198 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.077 | 0.013 | 0.077 | Prolactin release inhibitor | 0.059 0.058 CID_3035711 | ||
| 0.074 | 0.012 | 0.082 | Squalene epoxidase inhibitor | 0.082 0.009 CID_3035711 | CID_3035711 | |
| 0.117 | 0.055 | 0.117 | GABA C receptor antagonist | 0.104 0.072 CID_3035711 | ||
| 0.183 | 0.121 | 0.183 | Nitric-oxide synthase stimulant | |||
| 0.109 | 0.052 | 0.109 | UDP-glucose 4-epimerase inhibitor | 0.087 0.078 CID_3035711 | ||
| 0.146 | 0.09 | 0.146 | Growth hormone agonist | |||
| 0.173 | 0.118 | 0.173 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.093 | 0.039 | 0.093 | Glycine receptor antagonist | 0.075 0.065 CID_3035711 | ||
| 0.105 | 0.052 | 0.105 | Electrolyte absorption antagonist | 0.09 0.074 CID_3035711 | ||
| 0.057 | 0.005 | 0.057 | Benzodiazepine receptor peripheral-type antagonist | 0.047 0.008 CID_3035711 | ||
| 0.075 | 0.023 | 0.075 | Ornithine carbamoyltransferase inhibitor | 0.048 0.042 CID_3035711 | ||
| 0.242 | 0.19 | 0.242 | Analgesic | |||
| 0.092 | 0.04 | 0.115 | CYP2A6 inhibitor | 0.115 0.029 CID_3035711 | CID_3035711 | |
| 0.105 | 0.055 | 0.105 | GABA C receptor rho-1 antagonist | |||
| 0.119 | 0.077 | 0.119 | Cathepsin H inhibitor | |||
| 0.056 | 0.015 | 0.056 | Neurokinin 2 agonist | |||
| 0.072 | 0.033 | 0.072 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 CID_3035711 | ||
| 0.08 | 0.043 | 0.08 | Aminopeptidase I inhibitor | 0.067 0.058 CID_3035711 | ||
| 0.064 | 0.027 | 0.064 | Ryanodine receptor antagonist | |||
| 0.055 | 0.019 | 0.055 | Cytokine production stimulant | |||
| 0.174 | 0.142 | 0.23 | Spasmolytic | 0.23 0.1 CID_3035711 | CID_3035711 | |
| 0.063 | 0.033 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.048 | 0.019 | 0.048 | Acetyl-CoA transferase 1 inhibitor | 0.04 0.03 CID_3035711 | ||
| 0.054 | 0.025 | 0.054 | Potassium channel Kv1.3 blocker | |||
| 0.064 | 0.037 | 0.064 | Bombesin 1 receptor agonist | |||
| 0.051 | 0.025 | 0.051 | Benzodiazepine antagonist | 0.044 0.042 CID_3035711 | ||
| 0.05 | 0.024 | 0.05 | Leukocyte elastase inhibitor | |||
| 0.101 | 0.076 | 0.141 | Mucolytic | 0.141 0.038 CID_3035711 | CID_3035711 | |
| 0.065 | 0.04 | 0.065 | Protease activated receptor antagonist | |||
| 0.035 | 0.011 | 0.035 | Thiazolidinedione | |||
| 0.034 | 0.01 | 0.034 | Estrogen-related receptor gamma antagonist | 0.03 0.015 CID_3035711 | ||
| 0.143 | 0.12 | 0.143 | Phospholipase C inhibitor | |||
| 0.12 | 0.097 | 0.12 | Nav1.6 sodium channel blocker | |||
| 0.058 | 0.037 | 0.058 | Alcohol oxidase inhibitor | |||
| 0.073 | 0.053 | 0.073 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.091 | 0.071 | 0.091 | Sphingomyelinase inhibitor | |||
| 0.042 | 0.023 | 0.042 | Membrane dipeptidase inhibitor | |||
| 0.072 | 0.053 | 0.072 | Glutamate dehydrogenase inhibitor | |||
| 0.081 | 0.062 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.081 | 0.063 | 0.081 | Calcium antagonist | |||
| 0.053 | 0.037 | 0.053 | Alpha-mannosidase inhibitor | |||
| 0.048 | 0.033 | 0.048 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.044 | 0.03 | 0.044 | Geranyltranstransferase inhibitor | 0.044 0.031 CID_3035711 | ||
| 0.106 | 0.091 | 0.106 | Amylase inhibitor | |||
| 0.028 | 0.013 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 CID_3035711 | ||
| 0.091 | 0.077 | 0.091 | Anabolic | |||
| 0.102 | 0.088 | 0.112 | Microtubule formation inhibitor | 0.112 0.071 CID_3035711 | CID_3035711 | |
| 0.08 | 0.068 | 0.08 | D-Ala-D-Ala ligase inhibitor | |||
| 0.038 | 0.026 | 0.038 | Diamine oxidase inhibitor | |||
| 0.138 | 0.125 | 0.138 | Lipocortins synthesis antagonist | |||
| 0.087 | 0.075 | 0.087 | Creatine kinase inhibitor | |||
| 0.056 | 0.045 | 0.056 | Biliverdin reductase inhibitor | |||
| 0.087 | 0.076 | 0.087 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.038 | 0.028 | 0.038 | Alpha 1d adrenoreceptor agonist | |||
| 0.089 | 0.08 | 0.089 | Nitric-oxide synthase inhibitor | |||
| 0.016 | 0.007 | 0.016 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 CID_3035711 | ||
| 0.059 | 0.051 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.028 | 0.02 | 0.028 | Purinergic P2Y15 antagonist | |||
| 0.061 | 0.053 | 0.061 | Calcium channel P-type blocker | |||
| 0.027 | 0.02 | 0.035 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.035 0.015 CID_3035711 | CID_3035711 | |
| 0.046 | 0.041 | 0.046 | Dopamine beta hydroxylase inhibitor | |||
| 0.056 | 0.051 | 0.056 | NMDA receptor glycine site agonist | |||
| 0.057 | 0.053 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.06 | 0.056 | 0.06 | Phosphofructokinase-1 inhibitor | |||
| 0.048 | 0.045 | 0.048 | Acetyl-CoA transferase inhibitor | |||
| 0.191 | 0.187 | 0.191 | Vasodilator, peripheral | |||
| 0.049 | 0.045 | 0.08 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.08 0.016 CID_3035711 | CID_3035711 | |
| 0.018 | 0.014 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 CID_3035711 | CID_3035711 | |
| 0.055 | 0.052 | 0.055 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.065 | 0.062 | 0.065 | Glutamate decarboxylase inhibitor | |||
| 0.036 | 0.034 | 0.036 | Toll-Like receptor 2 agonist | |||
| 0.034 | 0.032 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.045 | 0.043 | 0.045 | Topoisomerase II beta inhibitor | |||
| 0.069 | 0.068 | 0.069 | Vanilloid 4 agonist | |||
| 0.049 | 0.048 | 0.049 | Argininosuccinate synthase inhibitor | |||
| 0.05 | 0.049 | 0.05 | Epithelial sodium channel blocker | |||
| 0.058 | 0.057 | 0.058 | Acetylcholine M5 receptor agonist | |||
| 0.062 | 0.066 | 0.093 | Exportin-1 inhibitor | 0.093 0.013 CID_3035711 | CID_3035711 | |
| 0.011 | 0.024 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 CID_3035711 | CID_3035711 | |
| 0.029 | 0.044 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.035 0.029 CID_3035711 | CID_3035711 | |
| 0.061 | 0.078 | 0.127 | Analgesic, opioid | 0.127 0.02 CID_3035711 | CID_3035711 | |
| 0.107 | 0.132 | 0.128 | Sphingosine 1-phosphate receptor 2 antagonist | 0.128 0.078 CID_3035711 | CID_3035711 | |
| 0.098 | 0.127 | 0.151 | Antibacterial (Helicobacter pylori) | 0.151 0.045 CID_3035711 | CID_3035711 | |
| 0.075 | 0.105 | 0.11 | Expectorant | 0.11 0.059 CID_3035711 | CID_3035711 | |
| 0.015 | 0.053 | 0.019 | Toll-Like receptor 8 agonist | 0.019 0.018 CID_3035711 | CID_3035711 | |
| 0.057 | 0.096 | 0.089 | Macrophage migration inhibitory factor inhibitor | 0.089 0.042 CID_3035711 | CID_3035711 | |
| 0.067 | 0.107 | 0.111 | Alcohol dehydrogenase inhibitor | 0.111 0.042 CID_3035711 | CID_3035711 | |
| 0.017 | 0.061 | 0.034 | Glucose-dependent insulinotropic receptor agonist | 0.034 0.024 CID_3035711 | CID_3035711 | |
| 0.045 | 0.089 | 0.059 | Beta adrenoreceptor antagonist | 0.059 0.058 CID_3035711 | CID_3035711 | |
| 0.002 | 0.072 | 0.01 | DNA polymerase III subunit alpha inhibitor | 0.01 0.003 CID_3035711 | CID_3035711 | |
| 0.045 | 0.116 | 0.071 | Epoxide hydrolase inhibitor | 0.071 0.052 CID_3035711 | CID_3035711 | |
| 0.104 | 0.179 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.116 CID_3035711 | CID_3035711 | |
| 0.13 | 0.207 | 0.193 | DNA damaging | 0.193 0.121 CID_3035711 | CID_3035711 | |
| 0.105 | 0.185 | 0.128 | Pregnane X receptor agonist | 0.128 0.105 CID_3035711 | CID_3035711 | |
| 0.135 | 0.241 | 0.194 | Peptidyltransferase inhibitor | 0.194 0.107 CID_3035711 | CID_3035711 | |
| 0.05 | 0.169 | 0.092 | Gastric antisecretory | 0.092 0.075 CID_3035711 | CID_3035711 | |
| 0.067 | 0.191 | 0.111 | Cyclooxygenase inhibitor | 0.111 0.11 CID_3035711 | CID_3035711 | |
| 0.073 | 0.239 | 0.128 | Heat shock protein 90 antagonist | 0.128 0.101 CID_3035711 | CID_3035711 | |
| 0.022 | 0.282 | 0.051 | Cathepsin B inhibitor | 0.051 0.047 CID_3035711 | CID_3035711 | |
| 0.086 | 0.35 | 0.142 | Death-associated protein kinase 2 inhibitor | 0.142 0.125 CID_3035711 | CID_3035711 | |
| 0.055 | 0.422 | 0.225 | Cardiotonic | 0.225 0.099 CID_3035711 | CID_3035711 | |
| 0.005 | 0.886 | 0.055 | H+/K+-transporting ATPase inhibitor | 0.055 0.03 CID_3035711 | CID_3035711 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |